stoxline Quote Chart Rank Option Currency Glossary
  
Aurinia Pharmaceuticals Inc. (AUPH)
16.25  -0.025 (-0.15%)    12-26 16:00
Open: 16.28
High: 16.34
Volume: 466,004
  
Pre. Close: 16.275
Low: 16.12
Market Cap: 2,142(M)
Technical analysis
2025-12-26 4:37:33 PM
Short term     
Mid term     
Targets 6-month :  19.31 1-year :  22.56
Resists First :  16.54 Second :  19.31
Pivot price 15.9
Supports First :  15.4 Second :  14.69
MAs MA(5) :  16.24 MA(20) :  15.84
MA(100) :  13.35 MA(250) :  0
MACD MACD :  0.3 Signal :  0.4
%K %D K(14,3) :  82.8 D(3) :  84.7
RSI RSI(14): 62.6
52-week High :  16.54 Low :  6.55
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ AUPH ] has closed below upper band by 17.9%. Bollinger Bands are 52.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 16.36 - 16.45 16.45 - 16.51
Low: 15.93 - 16.02 16.02 - 16.09
Close: 16.12 - 16.26 16.26 - 16.37
Company Description

Headline News

Fri, 26 Dec 2025
Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Thu, 25 Dec 2025
Aurinia Pharmaceuticals (NASDAQ:AUPH) rises 3.1% this week, taking three-year gains to 292% - simplywall.st

Mon, 22 Dec 2025
Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 12-Month High - Here's Why - MarketBeat

Tue, 16 Dec 2025
Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms (NASDAQ:AUPH) - Seeking Alpha

Mon, 15 Dec 2025
Marex Group plc Buys Shares of 135,000 Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Thu, 11 Dec 2025
Aurinia Pharmaceuticals Inc $AUPH Shares Purchased by Jump Financial LLC - MarketBeat

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Industry:
Shares Out 132 (M)
Shares Float 128 (M)
Held by Insiders 7.1 (%)
Held by Institutions 50.7 (%)
Shares Short 8,440 (K)
Shares Short P.Month 8,320 (K)
Stock Financials
EPS 0.56
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.76
Profit Margin 29.2 %
Operating Margin 40.4 %
Return on Assets (ttm) 9.4 %
Return on Equity (ttm) 20.6 %
Qtrly Rev. Growth 8.3 %
Gross Profit (p.s.) 1.61
Sales Per Share 2.01
EBITDA (p.s.) 0.76
Qtrly Earnings Growth 130 %
Operating Cash Flow 120 (M)
Levered Free Cash Flow 85 (M)
Stock Valuations
PE Ratio 29.01
PEG Ratio 0
Price to Book value 5.86
Price to Sales 8.05
Price to Cash Flow 17.83
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android